Abstract
Introduction Contact patterns are an important determinant of infection transmission. CONQUEST (COroNavirus QUESTionnaire) is an online survey of contacts for University of Bristol (UoB) staff and students. Results from 23/06/2020-24/11/2020 are used to investigate contact patterns among staff/students throughout various UK COVID-19 guidance periods.
Methods Responses captured self-reported contacts on the previous day, with COVID-19 guidance periods split: post-first lockdown (23/06/2020-03/07/2020), relaxed guidance period (04/07/2020-13/09/2020), “rule-of-six” period (14/09/2020-04/11/2020), and the second lockdown (05/11/2020-25/11/2020).
Results 722 staff (4199 responses) (mean household size: 2.6) and 738 students (1906 responses) (mean household size: 4.5) were included in the study. For staff, median contacts on the previous day were higher in the relaxed guidance and “rule-of-six” periods (3) than the post-lockdown and second lockdown periods (2). Mean contacts were higher during these two middle periods (4-6 per week) than the post-lockdown and second lockdown periods (~3). Mean contacts dropped between the last two periods (5.4 to 3.3), driven by a mean reduction in contacts in non-home/university locations (2.9 to 1.2).
Few students responded until October. After 05/10/2020, the median was 2 and the mean was around 6-7 each week, until the second lockdown when it dropped to ∼4. Mean number of contacts dropped between the last two periods (6.3 to 4.0) driven by a reduction in all contact types, including UoB contacts (3.5 to 2.5).
Discussion The mean and median number of contacts for UoB staff and students were low compared to pre-COVID-19 studies throughout the survey period and lowest during the second lockdown.
Competing Interest Statement
HC has received research funding from Sanofi Pasteur, IMS Health, AstraZeneca, and GSK unrelated to this research. JGW has received research funding from Gilead Sciences unrelated to this research. All other authors declare no competing interests.
Funding Statement
This study was funded and supported by the Elizabeth Blackwell Institute, HC, AF, KT, and EBP would like to acknowledge support from the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation at the University of Bristol. HC is additionally funded through an NIHR Career Development Fellowship [CDF-2018-11-ST2-015]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. CR is a member of the MRC Integrative Epidemiology Unit and receives support from the MRC (MC_UU_00011/5) and the University of Bristol. EN and EBP are supported by the MRC (MR/V038613/1). ATh is supported by Wellcome (217509/Z/19/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted on the 14th May 2020 by the Health Sciences University Research Ethics Committee at the University of Bristol (ID 104903), with four amendment requests approved on the 22nd May 2020, 9th June 2020, 27th August 2020 and 7th September 2020. The purpose of the amendments were either to update the relevance of the questions or to make the survey faster and easier to complete. All research was performed in accordance with the University of Bristol Ethics of Research Policy and Procedure (http://www.bristol.ac.uk/media-library/sites/red/documents/research-governance/Ethics_Policy_v8_03-07-19.pdf). Participants were aged 18 or older, voluntarily opted-in to the study and were required to give their informed consent before starting the survey.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Joint first authors
Competing interests: HC has received research funding from Sanofi Pasteur, IMS Health, AstraZeneca, and GSK unrelated to this research. JGW has received research funding from Gilead Sciences unrelated to this research. All other authors declare no competing interests.
Funding: This study was funded and supported by the Elizabeth Blackwell Institute, HC, AF, KT, and EBP would like to acknowledge support from the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation at the University of Bristol. HC is additionally funded through an NIHR Career Development Fellowship [CDF-2018-11-ST2-015]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. CR is a member of the MRC Integrative Epidemiology Unit and receives support from the MRC (MC_UU_00011/5) and the University of Bristol. EN and EBP are supported by the MRC (MR/V038613/1). ATh is supported by Wellcome (217509/Z/19/Z).
Data Availability
Data are available from the corresponding author.
